Louisiana State Employees Retirement System Takes Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Louisiana State Employees Retirement System bought a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 64,900 shares of the real estate investment trust’s stock, valued at approximately $926,000.

A number of other institutional investors have also modified their holdings of the stock. Tennessee Valley Asset Management Partners acquired a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $25,000. Cerity Partners LLC acquired a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $232,000. Custom Index Systems LLC acquired a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $547,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Sabra Health Care REIT by 1.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 760,836 shares of the real estate investment trust’s stock valued at $10,857,000 after purchasing an additional 13,349 shares during the period. Finally, International Assets Investment Management LLC increased its holdings in shares of Sabra Health Care REIT by 748.0% in the fourth quarter. International Assets Investment Management LLC now owns 4,681 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 4,129 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Mizuho upped their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a report on Tuesday, January 30th. They set a “buy” rating and a $21.00 price objective on the stock. Finally, Wedbush reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, February 29th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $15.77.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $13.65 on Friday. The business’s 50-day moving average price is $14.06 and its 200 day moving average price is $14.04. Sabra Health Care REIT, Inc. has a twelve month low of $10.30 and a twelve month high of $14.91. The company has a market capitalization of $3.16 billion, a PE ratio of 273.00, a price-to-earnings-growth ratio of 4.95 and a beta of 1.16. The company has a current ratio of 3.41, a quick ratio of 3.41 and a debt-to-equity ratio of 0.86.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Investors of record on Tuesday, February 13th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Monday, February 12th. This represents a $1.20 annualized dividend and a yield of 8.79%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 2,400.00%.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.